CJC-1295 With DAC

Also known as: CJC-1295 DAC, CJC-1295 with Drug Affinity Complex

What is it? 

CJC-1295 with DAC is a long-acting version of growth hormone-releasing hormone. A chemical modification allows it to bind to a blood protein (albumin) and stay active for up to 10 days after a single dose – unlike the short-acting No DAC version. 

—

Key Benefits (from research) 

– Stays active in the body longer – The DAC modification allows it to bind to albumin in the blood, extending its half–life to 8-10 days in humans versus minutes for unmodified GHRH. 

– Sustained GH and IGF-1 elevation – The pivotal human trial showed 2-10-fold GH increases lasting 6 days and 30-90% IGF-1 increases lasting up to 11 days from a single dose.

– Works with your body’s natural rhythms – Like other GHRH–class compounds, it preserves pulsatile GH release rather than flooding the system with a flat hormone dose. 

– Releases the full range of natural GH forms – Stimulating the pituitary produces a more complete mix of growth hormone variants than injecting synthetic growth hormone directly. 

– Improves metabolic markers in GH-deficient states – Research links sustained GHRH stimulation to reduced visceral fat, improved cholesterol profiles, and better endothelial function. 

– Ageing and somatopause research – Gerontology reviews identify CJC-1295 with DAC as a candidate for studying the age-related decline in growth hormone output. 

—-

Quick Q&A 

What is CJC-1295 with DAC used for in research? 

It is used to study sustained growth hormone stimulation, GH pulsatility, downstream metabolic effects, and age-related GH decline, using its extended half-life as a pharmacological advantage. 

Is it approved for people? 

No – it is sold for laboratory research only. 

Important Notice 

Sold for laboratory research only. Not for human use. Must be 18+.